• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Madhavbaug Share Price

    Vaidya Sane Ayurved Laboratories Share PriceVaidya Sane Ayurved Laboratories

    Small Cap Result
    ₹249.00
    19.65 (8.57%)
    As on 02 December, 2023 | 17:47 BSE: NSE: MADHAVBAUGISIN: INE0JR301013

    Vaidya Sane Ayurved Laboratories Performance

    Day Range

    • Low 220.00
    • High 250.00
    ₹ 249.00

    52 Week Range

    • Low 135.10
    • High 376.95
    ₹ 249.00
    • Open Price223.65
    • Previous Close229.35
    • Volume28800

    Start SIP in Vaidya Sane Ayurved Laboratories

    Start SIP

    Vaidya Sane Ayurved Laboratories Share Price

    • Over 1 Month -15.59%
    • Over 3 Month -28.65%
    • Over 6 Month 0.61%
    • Over 1 Year 82.55%

    Vaidya Sane Ayurved Laboratories Key Statistics

    P/E Ratio
    PEG Ratio
    Market Cap Cr 262
    Price to Book Ratio 6.5
    EPS 4.9
    Dividend 0
    Relative Strength Index 39.49
    Money Flow Index 27.15
    MACD Signal -12.87
    Average True Range 12.24

    Vaidya Sane Ayurved Laboratories Investment Rating

    • Master Rating:

    • Vaidya Sane Ayurved Laboratories has an operating revenue of Rs. 99.17 Cr. on a trailing 12-month basis. An annual revenue growth of 34% is outstanding, Pre-tax margin of 6% is okay, ROE of 11% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 34 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 65 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    N/A

    Price Strength

    Buyer Demand

    Group Rank

    Vaidya Sane Ayurved Laboratories Financials
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 10075
    Operating Expenses Annual Cr 9168
    Operating Profit Annual in Cr 87
    Depreciation Cr 32
    Interest Annual Cr 00
    Tax Annual Cr 21
    Net Profit Annual Cr 53
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr -13
    Cash from Investing Activity Annual Cr -8
    Cash from Financing Annual Activity Cr 22
    Net Cash Flow Annual Cr 2
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 4136
    Fixed Assets Annual Cr 2318
    Total Non Current Assets Annual Cr 2624
    Total Current Assets Annual Cr 2927
    Total Assets Annual Cr 5552
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 3934
    ROE Annual % 1310
    ROCE Annual % 1713
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1010
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 101
    Operating Expenses Annual Cr 91
    Operating Profit Annual in Cr 8
    Depreciation Cr 3
    Interest Annual Cr 0
    Tax Annual Cr 2
    Net Profit Annual Cr 5
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 40
    Fixed Assets Annual Cr 23
    Total Non Current Assets Annual Cr 27
    Total Current Assets Annual Cr 28
    Total Assets Annual Cr 55
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 38
    ROE Annual % 12
    ROCE Annual % 16
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 9
    Invest in Vaidya Sane Ayurved Laboratories

    Vaidya Sane Ayurved Laboratories Technicals

    EMA & SMA

    Current Price
    ₹249.00
    19.65 (8.57%)
    pointer
    • Bullish Moving Average
    • ___
    • 3
    • Bearish Moving Average
    • ___
    • 13
    • 20 Day
    • ₹264.35
    • 50 Day
    • ₹283.08
    • 100 Day
    • ₹285.40
    • 200 Day
    • ₹265.39
    • 20 Day
    • ₹271.96
    • 50 Day
    • ₹290.03
    • 100 Day
    • ₹305.08
    • 200 Day
    • ₹267.51

    Vaidya Sane Ayurved Laboratories Resistance and Support

    PIVOT
    ₹239.67
    Resistance
    First Resistance 259.33
    Second Resistance 269.67
    Third Resistance 289.33
    RSI 39.49
    MFI 27.15
    MACD Single Line -12.87
    MACD -15.54
    Support
    First Resistance 229.33
    Second Resistance 209.67
    Third Resistance 199.33

    Vaidya Sane Ayurved Laboratories Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 28,800 1,999,872 69.44
    Week 15,800 1,249,938 79.11
    1 Month 10,400 859,040 82.6
    6 Month 12,685 1,022,141 80.58

    Vaidya Sane Ayurved Laboratories Result Highlights

    Vaidya Sane Ayurved Laboratories Synopsis

    NSE-Medical-Hospitals

    Vaidya Sane Ayurved belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 99.03 Cr. and Equity Capital is Rs. 10.51 Cr. for the Year ended 31/03/2023. Vaidya Sane Ayurved Laboratories Ltd. is a Public Limited Listed company incorporated on 06/04/1999 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L73100PN1999PLC013509 and registration number is 013509.
    Market Cap 262
    Sales 99
    Shares in Float 0.36
    No of funds
    Yield 0.1
    Book Value 6.41
    U/D Vol ratio 0.6
    LTDebt / Equity
    Alpha 0.28
    Beta 0.69

    Vaidya Sane Ayurved Laboratories

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 66.34%66.34%66.34%66.34%
    Individual Investors 22.92%23.91%24.24%24.28%
    Others 10.74%9.75%9.42%9.38%

    Vaidya Sane Ayurved Laboratories Management

    Name Designation
    Dr. Rohit Madhav Sane Managing Director & CEO
    Dr. Vidyut B Ghag Whole Time Director
    Dr. Sushrut R Dambal Independent Director
    Mr. Mahesh P Kshirsagar Independent Director
    Mr. Ratnakar V Rai Independent Director

    Vaidya Sane Ayurved Laboratories Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Vaidya Sane Ayurved Laboratories Corporate Action

    Date Purpose Remarks
    2023-05-27 Audited Results & Dividend
    2022-11-10 Quarterly Results
    Date Purpose Remarks
    2022-11-18 INTERIM Declaration of Interim dividend at the rate of 0.25 per share {2.5%}.

    Vaidya Sane Ayurved Laboratories FAQs

    What is Share Price of Vaidya Sane Ayurved Laboratories ?

    Vaidya Sane Ayurved Laboratories share price is ₹249 As on 02 December, 2023 | 17:33

    What is the Market Cap of Vaidya Sane Ayurved Laboratories ?

    The Market Cap of Vaidya Sane Ayurved Laboratories is ₹261.8 Cr As on 02 December, 2023 | 17:33

    What is the P/E ratio of Vaidya Sane Ayurved Laboratories ?

    The P/E ratio of Vaidya Sane Ayurved Laboratories is As on 02 December, 2023 | 17:33

    What is the PB ratio of Vaidya Sane Ayurved Laboratories ?

    The PB ratio of Vaidya Sane Ayurved Laboratories is 6.5 As on 02 December, 2023 | 17:33

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.